Nancy J. Kelley, Founding Executive Director of the NYGC, center, discussed the organization’s services, including information about genome sequencing and bioinformatics.
STONY BROOK, N.Y., November 28, 2012 – Stony Brook University hosted a presentation by leaders from New York Genome Center (NYGC) on November 14 about the organization’s service offerings and plans to transform biomedical research in New York State and the region. Stony Brook University is one of 11 Institutional Founding Members of the collaborative venture. The presentation at Stony Brook was one in a series of Information Sessions presented by the NYGC for the research communities of Institutional Founding Members.
More than 150 attended the NYGC Information Session at Stony Brook, including many faculty from Stony Brook University.
During the NYGC Information Session, Nancy J. Kelley, Founding Executive Director of the NYGC, said the goal of the collaborative venture will be to increase the quality and speed of medical research outcomes in a new era of genomic medicine, to become an engine for life science commercialization in the region, and to accelerate the development of new diagnostics and treatments for conditions affecting millions, such as cancer, neurological disorders, and cardiovascular diseases.
About the New York Genome Center (NYGC):
The NYGC began offering services in February 2012 to members and other scientific and clinical organizations. These services include genome sequencing, bioinformatics, data storage, as well as whole genome sequencing, exome sequencing, and RNA-sequencing. The organization plans to build a permanent facility in Manhattan that is expected to be complete and operational by mid-2013. For more about NYGC, see this webpage.